Gifts and perks
Medical professionals known to prescribe Nuedexta receive large amounts of money and gifts from Avanir. Even though this practice is legally acceptable, it is still a controversial one. In a blatant use of this practice, Otsuka, the parent company of Avanir, recently spent $4.6 million on “traveling and dining expenses” of doctors. Many doctors prescribing Nuedexta to their patients have been enjoying their share of monetary and other benefits.
Side effects of Nuedexta
Nuedexta is suspected to have various side effects. Ever since its introduction to the market, there have been reports of patients suffering from side effects. Some of the cases have been reported to the FDA. According to these reports, the side effects patients experienced after consuming this drug include:
- Abdominal pain
- Muscle spasms
- Peripheral edema
- Urinary tract infections
Side effects such as rashes and dizziness were the most common ones. However, some of the more severe side effects may have also contributed to elderly patients suffering from severe or life-threatening consequences. This has given rise to more controversies about Nuedexta, with critics questioning the approval granted to this drug. The FDA has, however, declined to comment on these negative reports as yet.
But one of the reports by the FDA has noted that Nuedexta has resulted in the following consequences:
- 113 hospitalizations (including deaths)
- 51 deaths in total
- 102 people being sedated
- 101 cases of dizziness and eventual falls
The plight of the sufferers
Avanir received its FDA approval in 2011. The company quickly grew into a pharmaceutical giant, which has raised many eyebrows. The reality, however, may be that for every family that suffers the consequences of Nuedexta, the company gains. The manufacturer appears to be oblivious to the plight of the patients and their families who see their loved ones suffer.Related: 9 Secrets Your Nurses Know
Family members of the sufferers have regularly reported how Nuedexta made their condition worse. A few even reported their elderly patients becoming comatose after taking the drug.
There was a case of an 86-year old woman whose health worsened quickly after she received Nuedexta. The drug’s dosage for her was increased later, which led to further deterioration of her condition. Even after the drug was stopped, she was unable to recover back her health. Eventually, her kidneys failed, leading her to death.
In another case, an 88-year old woman living in a nursing home was placed on Nuedexta dosage. Her family still questions why she was she even prescribed the drug. The family suspects money is the motivation behind this. They took matters into their own hands and discovered that their doctor had received $100,000 during the time the woman was in the nursing home. For two years the old woman has been taken off the drug. Though she is doing slightly better than before, she has still not completely recovered.
Will there ever be an end to the ordeal of vulnerable patients and families who continue to suffer at the hands of aggressive pharmaceutical businesses and doctors who may be willing to compromise medical ethics in return for financial benefit?